Journal
EPILEPSIA
Volume 51, Issue 10, Pages 2207-2210Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1528-1167.2010.02646.x
Keywords
Complex-partial status epilepticus; Outcome; Serum level
Categories
Funding
- UCB
- Pfizer
- Astra-Zeneca
- Janssen-Cilag
Ask authors/readers for more resources
P>Oral antiepileptic drugs (AEDs) represent possible add-on options in refractory status epilepticus (SE). In this setting, pregabalin (PGB) has not been reported before. Over the last 42 months, we identified 11 SE episodes (10 patients) treated with PGB in our hospital. Its use was prompted by the favorable pharmacokinetic profile, devoid of drug-drug interactions. The patients mostly had refractory, partial SE. Only two patients were managed in the intensive care unit (ICU). We found a definite electroclinical response in 5 of 11, already evident 24 h after PGB introduction, and a possible response (concomitantly with other AEDs) in 3 of 11 of the episodes; 3/11 did not respond. The treatment was well tolerated. Partial SE appeared to better respond than generalized convulsive SE. PGB appears to be an interesting option as add-on treatment in refractory partial SE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available